Clinical Trials Browser

Phase 3 × Unknown × Immune Checkpoint Inhibitors × Clear all

NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Phase 3 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04229355 2021-02-09

DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular